Adjuvants suffer politics

The science of vaccine supply-stretching adjuvants--approved and used in some European countries--appears to be getting overwhelmed by political concerns about their safety. Fear mongering has stalled their use in the U.S. Interview

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.